CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Immunome Says FDA Accepted NDA for Desmoid Tumors Drug

NDA FilingPositive
AI Analysis

Summary

Immunome announced that the FDA has accepted its New Drug Application (NDA) for a desmoid tumors treatment, advancing the drug toward potential regulatory approval.

Outcome Details

FDA accepted NDA

Importance:7/10
Sentiment:
0.70
regulatoryNDAdesmoid tumorsoncology
Related Companies

Read the original article

Published by yahoo_finance on July 8, 2026 12:06 PM

Read Original